Firstkind is a UK based founder and manufacturer of the innovative geko® device – an advanced, clinically proven wound care therapy. Through its unique mechanism of non-invasive neuromuscular electrostimulation (NMES), the wearable geko device activates the calf and foot muscle pumps increasing venous, arterial, and microcirculatory blood flow, transporting oxygenated blood to the wound bed to promote accelerated wound healing in patients with chronic venous insufficiency and intermittent claudication. The geko device doubles the rate of chronic wound healing, reduces pain and oedema and improves concordance. It supports earlier intervention, reduces clinical burden and environmental impact, and contributes to more sustainable wound care pathways. The geko device is available on prescription.